重新审视当前大流行的可怕后果之一：COVID-19 中的肺栓塞。
Revisiting One of the Dreaded Outcomes of the Current Pandemic: Pulmonary Embolism in COVID-19.
机构信息
Corpus Christi Medical Center, Department of Pulmonary Medicine, Corpus Christi, TX 78412, USA.
Department of Medicine, Texas A&M University, College Station, TX 77843, USA.
出版信息
Medicina (Kaunas). 2020 Dec 3;56(12):670. doi: 10.3390/medicina56120670.
Pulmonary embolism (PE) is a commonly encountered clinical entity in patients with coronavirus disease 2019 (COVID-19). Up to 1/3 of patients have been found to have PE in the setting of COVID-19. Given the novelty of the virus causing this pandemic, it has not been easy to address diagnostic and management issues in PE. Ongoing research and publications of the scientific literature have helped in dealing with COVID-19 lately and this applies to PE as well. In this article, we attempt to succinctly yet comprehensively discuss PE in patients with COVID-19 with a review of the prevailing literature.
肺栓塞（PE）是 2019 年冠状病毒病（COVID-19）患者中常见的临床病症。高达 1/3 的 COVID-19 患者被发现存在 PE。鉴于引起此次大流行的病毒的新颖性，在处理 PE 的诊断和管理问题方面并不容易。最近，对冠状病毒的持续研究和科学文献的发表对 COVID-19 的处理有所帮助，PE 也是如此。在本文中，我们尝试通过对现有文献的回顾，简明而全面地讨论 COVID-19 患者中的 PE。
Zotero 插件